Clinical Trial Update: A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms [Phase 4]

View source ↗

Summary

This Phase 4 trial compared tolerability of an increased dose of enteric-coated mycophenolate acid in renal transplant patients whose mycophenolate mofetil dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Mycophenolic acid (enteric-coated) (mycophenolic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 4 | Status: TERMINATED | Results posted: 2011-03-11